MorphoSys AG ADR Analysis

MorphoSys Stock Analysis Notes

The company recorded a loss per share of 1.5. MorphoSys AG ADR had not issued any dividends in recent years. MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. The company was founded in 1992 and is headquartered in Planegg, Germany. Morphosys operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 648 people. To find out more about MorphoSys AG ADR contact the company at 49 89 899 27 0 or learn more at https://www.morphosys.com.

MorphoSys AG ADR Investment Alerts

MorphoSys AG ADR Upcoming and Recent Events

MorphoSys Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 2.86 B.

MorphoSys Profitablity

The company has Net Profit Margin of (1.91) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (9.6) %, which entails that for every $100 of revenue, it lost $9.6.

MorphoSys Outstanding Bonds

MorphoSys Technical and Predictive Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how MorphoSys prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MorphoSys shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as MorphoSys. By using and applying MorphoSys Stock analysis, traders can create a robust methodology for identifying MorphoSys entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.